Risk of ischemic heart disease in women after radiotherapy for breast cancer.
By S. Darby, M. Ewertz, P. McGale, A. Bennet, U. Blom-Goldman, D. Brønnum, C. Correa, D. Cutter, Giovanna Gagliardi, B. Gigante and 6 more. New England Journal of Medicine, 2013
3,618 citations recorded by the source corpus.
Subfields: Cancer Research, Cardiology and Cardiovascular Medicine, Oncology
View Paper: https://www.semanticscholar.org/paper/117a3dfc9cfce6bf799d00275acffeb3e60d2c58
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Gregory Y. H. Lip
- Jeroen J. Bax
- Helmut Baumgartner
- J. Herrmann
- Paulus Kirchhof
- Jose Luis Zamorano
- D. Lenihan
- P. Lancellotti
In Oncology
Citations in the corpus
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2017, neutral): “itant administration of other cardiotoxic drugs and patient factors (younger age, traditional risk factors [170], history of heart disease).”
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016, background): “The most exposed coronaries are the left anterior descending during left breast irradiation and the left main stem, circumflex and right coronary arteries during treatment for Hodgkin lymphoma.(132,133) A higher prevalence of stress test abnormalities has been found among women irradiated for left b”
- Cardiovascular disease in women (2010, neutral): “dose to the heart, beginning within a few years after exposure, and continuing for at least 20 years.(85) Women with preexist-”
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline (2016, positive): “monal/endocrine therapy with aromatase inhibitors have been associated with an increased risk of cardiovascular disease in patients with breast cancer.(70,71) The risk of heart disease increases in postmenopausal women, as endogenous estrogens in younger women contribute to the low preva-”
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016, background): “The most exposed coronaries are the left anterior descending during left breast irradiation and the left main stem, circumflex and right coronary arteries during treatment for Hodgkin lymphoma.(132,133) A higher prevalence of stress test abnormalities has been found among women irradiated for left b”